OPC Pharmaceutical JSC
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, external use, digestion, pain relief-anti-inflammatory, endocrine, and other d… Read more
Market Cap & Net Worth: OPC Pharmaceutical JSC (OPC)
OPC Pharmaceutical JSC (VN:OPC) has a market capitalization of $8.20K (₫208.37 Million) as of March 19, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #21426 globally and #156 in its home market, demonstrating a 2.26% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OPC Pharmaceutical JSC's stock price ₫22600.00 by its total outstanding shares 9220 (9.22K).
OPC Pharmaceutical JSC Market Cap History: 2015 to 2026
OPC Pharmaceutical JSC's market capitalization history from 2015 to 2026. Data shows growth from $3.51K to $8.20K (10.47% CAGR).
OPC Pharmaceutical JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OPC Pharmaceutical JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OPC by Market Capitalization
Companies near OPC Pharmaceutical JSC in the global market cap rankings as of March 19, 2026.
Key companies related to OPC Pharmaceutical JSC by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
OPC Pharmaceutical JSC Historical Marketcap From 2015 to 2026
Between 2015 and today, OPC Pharmaceutical JSC's market cap moved from $3.51K to $ 8.20K, with a yearly change of 10.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫8.20K | -5.83% |
| 2025 | ₫8.71K | -4.00% |
| 2024 | ₫9.07K | +10.70% |
| 2023 | ₫8.19K | -6.97% |
| 2022 | ₫8.81K | +15.87% |
| 2021 | ₫7.60K | +1.01% |
| 2020 | ₫7.53K | +36.37% |
| 2019 | ₫5.52K | -3.09% |
| 2018 | ₫5.69K | -14.03% |
| 2017 | ₫6.62K | +60.65% |
| 2016 | ₫4.12K | +17.49% |
| 2015 | ₫3.51K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of OPC Pharmaceutical JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.20K USD |
| MoneyControl | $8.20K USD |
| MarketWatch | $8.20K USD |
| marketcap.company | $8.20K USD |
| Reuters | $8.20K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.